XOMA Royalty (STU:X0M1) ROE % Adjusted to Book Value : -5.17% (As of Dec. 2024)

View and export this data going back to 1986. Start your Free Trial

What is XOMA Royalty ROE % Adjusted to Book Value?

XOMA Royalty's ROE % for the quarter that ended in Dec. 2024 was -19.60%. XOMA Royalty's PB Ratio for the quarter that ended in Dec. 2024 was 3.79. XOMA Royalty's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -5.17%.

XOMA Royalty ROE % Adjusted to Book Value Historical Data

The historical data trend for XOMA Royalty's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty ROE % Adjusted to Book Value Chart

XOMA Royalty Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.50

8.17

-8.02

-15.79

-4.36

XOMA Royalty Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-34.17	-12.70	26.68	-20.06	-5.17

Competitive Comparison of XOMA Royalty's ROE % Adjusted to Book Value

For the Biotechnology subindustry, XOMA Royalty's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

XOMA Royalty's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XOMA Royalty's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where XOMA Royalty's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

XOMA Royalty ROE % Adjusted to Book Value Calculation

XOMA Royalty's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-16.54%	/	3.79
	=	-4.36%

XOMA Royalty's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-19.60%	/	3.79
	=	-5.17%

XOMA Royalty ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA Royalty Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (STU:X0M1) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA 0M26:UK

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

XOMA Royalty Headlines

No Headlines